Streetbeat News

Stock Prices

BMY

Deutsche Bank has initiated coverage on Bristol-Myers Squibb with a Hold rating, causing the company's shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:23 pm

ABBV

Deutsche Bank has initiated coverage on AbbVie with a Hold rating, leading to a decrease in AbbVie's stock price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:21 pm

GILD

Deutsche Bank has initiated coverage on Gilead Sciences with a Hold rating, leading to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:21 pm

DIA

IWM

QQQ

SPY

Major indexes are lower after Federal Reserve Chair Powell stated that he is not confident the Fed has achieved a sufficiently restrictive stance.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:20 pm

XRTX

XORTX Therapeutics has announced a 1-for-9 share consolidation, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:19 pm

DXCM

Large investors, or 'whales', have taken a bearish stance on DexCom (NASDAQ:DXCM), with 68% of big-money traders showing bearish sentiment. The overall sentiment is split between 31% bullish and 68% bearish. The whales have been targeting a price range from $85.0 to $110.0 for DexCom over the last 3 months. The price of DXCM is up 0.59% at $93.31. Three professional analysts have given an average price target of $103.67 for DXCM.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 7:17 pm

APYX

Apyx Medical's shares are trading lower following the company's Q3 financial results, which were worse than expected.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:15 pm

MDXH

MDxHealth reported its Q3 financial results, which led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:13 pm

VIRX

Viracta Therapeutics reported worse-than-expected Q3 earnings per share (EPS) results, leading to a decrease in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:10 pm

SLDB

Solid Biosciences reported its Q3 financial results, leading to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 7:10 pm